Convergent synthesis and SAR of dolastatin 15 by solid phase coupling
Convergent synthesis and SAR of dolastatin 15 by solid phase coupling
批准号:
10672011
负责人:
AKAJI Kenichi
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dolastatin 15 is a cytostatic depsipeptide isolated from the marine mollusk Dolabella auricularia by Pettit et. al. in 1989. Among the dolastatins, an unprecedented series of linear and cyclic antineoplastic and/or cytostatic peptide isolated from the Indian Ocean sea hare, dolastatin 15 as well as dolastatin 10 represent the two most important members because of the strong and selective activities.For completing the synthesis of dolastatin 15, single step segment condensation between peptide fragment and nonpeptide fragment by the CIP/HOAt method was used, since activation at the Pro residue is resistance to isomerization. N, N-dimethylamino acid was incorporated in peptide fragment 2 since CIP-mediated activation is expected to be efficient enough for hindered couplings in solution. Pro, 2-hydroxyisovaleric acid (Hiva), and Phe was employed for the preparation of nonpeptide fragment. The Pyrrolidone ring of was constructed by the CIP-mediated coupling of Phe and Meldrum's ester employed as C2 unit. For the preparation of peptide fragment, CIP-mediated activation for the coupling of N-methylamino acid on solid support was selected as a preferable scheme to facilitate the practical synthesis of dolastatin 15. Thus, prior to the synthesis of dolastatin 15 according to the scheme, we evaluated CIP-mediated activation for its efficiency in preparing peptide sequence containing N-methylamino acids on solid support.In conclusion, a convergent synthesis utilizing single step condensation of fragment and pyrrolidone fragment using CIP-HOAt as an efficient coupling reagent was achieved. The CIP-mediated reaction was also successfully applied for coupling of N-methylamino acid on solid support, demonstrating the first practical application of the solid-phase procedure for natural product synthesis
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of an N-Methylamino Acid"J. Org. Chem.. 64(2). 405-411 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenichi Akaji: "Efficient Synthesis of Peptaibol Using a Chloro Imidazolidium Coupling Reagent,CIP" Tetrahedron. 53. 567-584 (1997)
Kenichi Akaji:“使用氯咪唑啉偶联试剂,CIP 有效合成 Peptaibol”四面体。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of N-Methylamino Acid"Peptide Chemistry,1998. 9-12 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”肽化学,1998 年。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenichi Akaji: "Convergent Synthesis of Dolastatin 15 by Solid Phase Coupling of N-Methylamino Acid"Peptide Chemistry, 1998. 9-12 (1999)
Kenichi Akaji:“通过 N-甲基氨基酸固相偶联合成多拉司他汀 15”肽化学,1998. 9-12 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Development of a novel persistent protease inhibitor containing D-amino acid
-
批准号:21590017
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:AKAJI Kenichi
-
依托单位:
Development of SARS virus inhibitor using unusual amino acid-containing natural products as seeds
-
批准号:18590010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:AKAJI Kenichi
-
依托单位:
Combinatorial Synthesis of Transition State Mimetic Inhibitor Using Asymmetric Aldol, Reaction
-
批准号:13672211
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:AKAJI Kenichi
-
依托单位:
Intramolecularcyclization by solid-phase olefination and its application to combinatorial synthesis
-
批准号:10557210
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:1998
-
负责人:AKAJI Kenichi
-
依托单位:
Convergent Synthesis of Anti-Cancer Alkaloid, Mirabazols, using a New Coupling Reagent
-
批准号:08672459
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:AKAJI Kenichi
-
依托单位:
Development of Low Molecular Weight HIV Protease Inhibitor for Oral Use
-
批准号:07557141
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1995
-
负责人:AKAJI Kenichi
-
依托单位:
海外基金